Phase 1b trial to study the effect of Ch-mAb7F9 in methamphetamine using subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2016
At a glance
- Drugs IXT-m200 (Primary)
- Indications Drug abuse
- Focus Adverse reactions; Therapeutic Use
- 26 Apr 2016 New trial record
- 16 Aug 2013 According to a InterveXion media release, company has been granted a meeting with FDA in January 2014 to review this Phase 1b study protocol.